BridgeMD
New treatment option for Optic Neuropathy
Official title Hyperbaric Oxygen Therapy for Optic Neuropathies
ClinicalTrials.gov ID: NCT06128720
What this study is testing
- What it's testing
- The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients must meet all of the following criteria to join the study (all eligibility criteria must be met at the screening and baseline visits unless...
- Participant must be at least 18.
- Participant must has the ability to comply with the requirements of the study and complete the schedule of events (SOE).
- Participant's with clinical evidence of optic neuropathy.
- Participant must understand and sign the informed consent. If the participant's vision is impaired to the point where he/she cannot read the informed...
You likely can't join if
- Participant is unable to comply with study procedures or follow-up visits.
- Participant has evidence of corneal opacification or lack of optical clarity.
- Participant is currently participating in or has within the last 3 months participated in any other clinical trial of a drug by ocular (if in the...
- Participant is pregnant or lactating.
- Participant has, in the opinion of the investigator, any physical or mental condition that would increase the risk of participation in the study or...
- Children and comatose patients.
See the full eligibility criteria
- Patients must meet all of the following criteria to join the study (all eligibility criteria must be met at the screening and baseline visits unless otherwise noted):
- Participant must be at least 18.
- Participant must has the ability to comply with the requirements of the study and complete the schedule of events (SOE).
- Participant's with clinical evidence of optic neuropathy.
- Participant must understand and sign the informed consent. If the participant's vision is impaired to the point where he/she cannot read the informed consent document, the document will be read to the participant in its...
- Participant is unable to comply with study procedures or follow-up visits.
- Participant has evidence of corneal opacification or lack of optical clarity.
- Participant is currently participating in or has within the last 3 months participated in any other clinical trial of a drug by ocular (if in the study eye) or systemic administration.
- Participant is pregnant or lactating.
- Participant has, in the opinion of the investigator, any physical or mental condition that would increase the risk of participation in the study or may interfere with the study procedures, evaluations and outcome...
- Children and comatose patients.
- Participant abusing drugs or alcohol.
- Prior treatment with hyperbaric oxygen within the last 6 months.
- Participant with claustrophobia or that cannot decompress properly.
The study team makes the final eligibility decision.
Where it's taking place
- Palo Alto, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Palo Alto, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.